Menu
Disease
A-Z
Health Topics
Alternative Medicine
Developmental Pediatrics
General Pediatrics
Genetics
Immunodeficiencies
Infectious Diseases
Laboratory Medicine
Neonatology
Nutrition
Pediatric Cardiology
View all Topics
Featured Articles
Diabetic ketoacidosis
Anaphylaxis
Urticaria (hives) and angioedema
Anal fissure
Circumcision
Skin allergies
Kids Corner
Health and Knowledge with fun.
Drugs &
Calculators
Medical Calculators
Drug Calculators
Growth Calculators
Renal Calculators
View all Calcualtors
Drug Index
ACE inhibitor
Alkylating agents
Allergies
View all Drugs
Poisoning Center
Aluminum phosphide
Anti-histaminics
Antidepressants
View all Drugs
Medical Eqipments
Monitors
Pumps
Incubators
View all Equipments
Diagnostic Aid
Get your diffrential
diagnosis.
Consult
& Posts
Ask a Doctor
Diagnostic Dilemma
Question of the Week
Pediatric Blogs
Spot Diagnosis
Grand Rounds
Pedi Poll
Pediatric
Journal
Current Issue
All Issues
Advance Access
About the Journal
Submit Article
Books
& Apps
Book Store
Pediatric Oncall
Medical Calculators
Vaccine Reminder
Pediatric Oncall Journal
Drug Center
Parenting
CME &
Videos
Upcoming Conferences
Conference Abstracts
MCQs
Videos
Vaccine
Reminder
Sign In
Diseases and Conditions
›
Pediatric Endocrinology
›
Precocious Puberty
Precocious Puberty
Dr. Mrs. Meena P. Desai
More..
Precocious Puberty - Treatment
Q. What are the goals of management in these children ?
A. The management is directed towards reversing and preventing further progression of puberty, arrest of skeletal maturation which compromises height potential and dealing with the emotional and psychologic problems which are frequently encountered. These children should be guarded against sexual abuse.
GNRH Agonist
Q. What are the indications for the use of GnRH agonist? How it should be given ?
A. The use of drugs in the idiopathic form of TPP is influenced by the age of onset of symptoms and rapidity of progression. When CPP is rapidly progressive and occurs in a young child with the possibility of compromising height potential, the best form of medical therapy available today is with GnRH agonist. Chronic administration of these compounds down regulates and desensitizes GnRH receptors on pituitary gonadotropes. This leads to inhibition of gonadotropin release followed by decreased secretion of sex steroids. Depending on the nature of the preparation, GnRH can be administered by the SC route or intranasally daily or in a long acting repository form every 4 weeks. Within 2-4 weeks of adequate treatment with these agonists, the mean LH response to GnRH is within the prepubertal range and the sex steroid levels are suppressed by 4-12 weeks. The secondary sex characters regress and the accelerated growth velocity and bone age advance are slowed during the first year of therapy.
Leuprolide Acetate (Lupron depot ped) is the only depot preparation approved in USA and is given as 0.25 to 0.3 mg/kg, minimum 7.5 mg IM once in 4 weeks. Triptorelin available here as (Decapeptyl) is used in doses of 60 to 75 mcg/kg IM once in 3 to 4 weeks. Aqueous daily S.C. injection of leuprolide 50 mcg/kg twice a day or intranasal nafarelin (Synarel) 800 mcg bid are other preparations.
Therapy should be monitored in these children at regular intervals, with gonadotropin and sex steroid levels maintained in prepubertal range in both the sexes. Skeletal maturation is retarded to a greater degree than linear growth with resultant increase in prediction for adult stature. Occasional allergic reaction may occur otherwise no toxic reactions are reported. Medical therapy is advisable for nonprogressive neurogenic lesions causing CPP including postmeningitic forms or hamartomas.
Treatment Modalities
Q. What treatment modalities are available ?
A. Treatment varies with the underlying cause.GnRH agonists, Medroxyprogesterone Acetate (MPA) and Cyproterone Acetate (CPA) are used for gonadotropin dependent CPP.
GnRH independent sexual precocity in the females (e.g. ovarian cysts) is usually treated with MPA, or occasionally with testolactone. In boys CAH is the usual cause of peripheral sexual precocity and is treated with corticosteroids. Testotoxicosis is a rare condition treated with ketoconazole, spironolactone and flutamide.
The normal variation of pubertal development such as a premature thelarche, premature isolated menarche and premature adrenarche are benign and self limited conditions requiring careful follow up without institution of therapy. Surgery, radiation, or chemotherapy are required for CNS tumor. Occasionally pedunculated hamartomas have been extirpated.
The unusual syndrome of sexual precocity associated with juvenile hypothyroidism is reversible with the institution of the thyroid therapy.
In peripheral incomplete forms of sexual precocity, GnRH-A is ineffective. Testolactone a competitive inhibitor of the enzyme aromatase which converts androgens to estrogens has been used in gonadotropin- independent McCune Albright Syndrome. MPA has been useful in the treatment of recurrent ovarian cysts, McCune Albright Syndrome and familial testotoxicosis. If TPP supervenes before/after treatment of PPP, GnRH-(A) therapy may be added.
Q. How effective are other forms of treatment in CPP ?
A. Medroxy progesterone acetate (MPA) has been administered I.M. in doses varying from 50 to 400mg per month (initially 100mg/m2 ) or daily orally as 5mg twice to four times a day. It is available freely, is more economical and is effective in controlling menses and secondary sex characters. Cyproterone acetate(CA) has been used in doses varying from 100 to 150 mg/m2 /day in 2-3 divided doses. Both MPA and CA can suppress gonadotropin secretion in addition CA has an antiandrogenic effect. Both these drugs have very little effect on linear growth or skeletal maturation, which continues to progress.
Q. Can normal pubertal development resume when GnRH treatment is discontinued? Any other problems related to treatment ?
A. Within 6 to 18 months of discontinuation of treatment, normal pubertal development is resumed. Long term use may decrease the bone mass density as skeletal calcification may be affected to some extent. Occasionally polycystic Ovarian Syndrome (PCOS) is described.
Dr. Mrs. Meena P. Desai
Precocious Puberty
Precocious Puberty
02/25/2001
02/25/2001
×
Contributor Information and Disclosures
Dr. Mrs. Meena P. Desai
Consultant Pediatrician
Sir Hurkisondas Nurrotumdas Hospital,
Hon. Director, Sir H.N. Medical Research Society,
Consultant-Endocrinology Division
Bai Jerbai Wadia Hospital For Children, and
Institute of Child Health & Research Centre.
First Created:
02/25/2001
×
References
<<
Precocious Puberty - Investigations
Normal Puberty in Girls
>>
Related
More from Precocious Puberty
Precocious Puberty - Introduction
Central Precocious Puberty (CPP) or True Precocious Puberty (TPP)
Precocious Puberty - Presentation
Precocious Puberty - Investigations
Normal Puberty in Girls
Normal Puberty in Boys
More from Pediatric Endocrinology
Congenital Adrenal Hyperplasia
Cushing's Syndrome
Diabetic Ketoacidosis
Growth Hormone Deficiency
Hypoglycemia - an Approach
View all from Pediatric Endocrinology
Ask a Doctor
Book Store
Pediatric Drug Index
Order Now
Recommended for you
Novel Influenza A (H1N1) Laboratory Testing
Rubella (German Measles)
Systemic Lupus Erythematosus (SLE)
Videos
Dr. Ira Shah: About Brain Teasers in Pediatric Infectious Diseases | Pediatric oncall
Diagnostic Dilemmas In TB #1 - How To Interpret Positive Mantoux Test?
Dr. Ira Shah | Diagnosis of MDRTB and XDRTB - How early can you Spot?
View All
Question Of The Week
Pedi Poll
What are the criteria for diagnosis of UTI in OPD in routine urine microscopic examination?
Answer
What is the role of ambroxal drops in infants and ...
A 2 yr old male child presenting with some hesitat...
Neutropenia lymphocytosis
Vaping-related lung injury linked to flavorings in conventional vape pens have been reported. Is nic...
Vote
In couples where one partner is HIV infected and the other uninfected, guidelines mention that uninf...
Should oseltamivir be given in all children with fever and cough even if the symptoms are mild_?
Pediatric Oncall Journal
Review Article
Metabolic Syndrome in Children: Definition, Risk Factors, Prevention and Management-A Brief Overview
Original Article
Cord blood Thyroid Stimulating Hormone Level - and the influence of perinatal and other factors on it
Case Reports
MCQ
MCQs on Immunization
MCQs on Neurology
MCQs Set 4
MCQs Set 3
Quiz on Kawasaki Disease
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
X
Sign In
Disease A-Z
Health Topics
Alternative Medicine
Developmental Pediatrics
General Pediatrics
Genetics
Immunodeficiencies
Infectious Diseases
Laboratory Medicine
Neonatology
Nutrition
Pediatric Cardiology
View all topics
Featured Articles
Diabetic ketoacidosis
Anaphylaxis
Urticaria (hives) and angioedema
Anal fissure
Circumcision
Skin allergies
Kids Corner
Drugs & Calculators
Medical Calculators
Drug Calculators
Growth Calculators
Renal Calculators
View all Calculators
Drug Index
ACE inhibitor
Alkylating agents
Allergies
View all Drugs
Poisoning Center
Aluminum phosphide
Anti-histaminics
Antidepressants
View all Drugs
Medical Eqipments
Monitors
Pumps
Incubators
View all Eqipments
Diagnostic Aid
Consult & Posts
Ask a Doctor
Diagnostic Dilemma
Question of the Week
Pediatric Blogs
Spot Diagnosis
Grand Rounds
Pedi Poll
Pediatric Oncall Journal
Current Issue
All Issues
Advance Access
About the Journal
Submit Article
Books & Apps
Book Store
Pediatric Oncall
Medical Calculators
Vaccine Reminder
Pediatric Oncall Journal
Drug Center
Parenting
CME & Videos
Upcoming Conferences
Conference Abstracts
MCQs
Videos
Vaccine Reminder
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0